HCV genotype 3–the new treatment challenge
J Ampuero, M Romero‐Gomez… - Alimentary …, 2014 - Wiley Online Library
Background Over the past several years, hepatitis C therapy has been pegylated interferon
and ribavirin based. Although protease inhibitor‐based therapy has enhanced response …
and ribavirin based. Although protease inhibitor‐based therapy has enhanced response …
HCV genotype 3-the new treatment challenge.
J Ampuero, M Romero-Gómez, KR Reddy - 2014 - cabidigitallibrary.org
Background: Over the past several years, hepatitis C therapy has been pegylated interferon
and ribavirin based. Although protease inhibitor-based therapy has enhanced response …
and ribavirin based. Although protease inhibitor-based therapy has enhanced response …
HCV genotype 3–the new treatment challenge.
J Ampuero, M Romero-Gómez… - Alimentary Pharmacology …, 2014 - europepmc.org
Background Over the past several years, hepatitis C therapy has been pegylated interferon
and ribavirin based. Although protease inhibitor-based therapy has enhanced response …
and ribavirin based. Although protease inhibitor-based therapy has enhanced response …
HCV genotype 3–the new treatment challenge
J Ampuero, M Romero-Gómez… - Alimentary …, 2014 - pubmed.ncbi.nlm.nih.gov
Background Over the past several years, hepatitis C therapy has been pegylated interferon
and ribavirin based. Although protease inhibitor-based therapy has enhanced response …
and ribavirin based. Although protease inhibitor-based therapy has enhanced response …
[引用][C] HCV genotype 3-the new treatment challenge
J Ampuero, M Romero-Gómez, KR Reddy - Alimentary Pharmacology & …, 2014 - cir.nii.ac.jp
Review article: HCV genotype 3 - the new treatment challenge | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
HCV genotype 3-the new treatment challenge.
J Ampuero, M Romero‐Gómez… - Alimentary …, 2014 - search.ebscohost.com
Background Over the past several years, hepatitis C therapy has been pegylated interferon
and ribavirin based. Although protease inhibitor-based therapy has enhanced response …
and ribavirin based. Although protease inhibitor-based therapy has enhanced response …
HCV genotype 3–the new treatment challenge
J Ampuero, M Romero‐Gómez, KR Reddy - Alimentary Pharmacology & …, 2014 - infona.pl
Background Over the past several years, hepatitis C therapy has been pegylated interferon
and ribavirin based. Although protease inhibitor‐based therapy has enhanced response …
and ribavirin based. Although protease inhibitor‐based therapy has enhanced response …
[引用][C] HCV genotype 3—the new treatment challenge
J AMPUERO, M ROMERO-GOMEZ… - Alimentary …, 2014 - pascal-francis.inist.fr
Review article: HCV genotype 3 — the new treatment challenge CNRS Inist Pascal-Francis CNRS
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …